
Cerise Pharmaceuticals Private Limited
Founded in 2014 and headquartered in Maharashtra, India.
Founded in 2014 and headquartered in Maharashtra, India.
Cerise Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 December 2014 and has a history of Ten years and two months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Berry Pharmaceuticals Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Satya Pandey and Shailesh Pandey serve as directors at the Company.
Thane, Maharashtra, India
+91-XXXXXXXXXX
-
U24132MH2014PTC260450
260450
Private Limited Indian Non-Government Company
29 Dec 2014
30 Sep 2018
31 Mar 2018
Unlisted
Roc Mumbai
Cerise Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Common Disease Medicines, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements, Dietary Supplements, Vitamin Tablets & Capsules, Skin Ointment, Pain Relief Drugs & Pharmaceuticals, Diclofenac.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satya Pandey ![]() | Director | 29-Dec-2014 | Current |
Shailesh Pandey ![]() | Director | 29-Dec-2014 | Current |
Cerise Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 1.06% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.27%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2017, Cerise Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cerise Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cerise Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cerise Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cerise Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records.
30 Sep 2018
Cerise Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai.
31 Mar 2018
Satya Prakash Pandey was appointed as a Director was appointed as a Director on 29 Dec 2014 & has been associated with this company since 10 years 2 months .
29 Dec 2014
Shailesh Kumar Pandey was appointed as a Director was appointed as a Director on 29 Dec 2014 & has been associated with this company since 10 years 2 months .
29 Dec 2014
Cerise Pharmaceuticals Private Limited was registered on 29 Dec 2014 with Roc Mumbai & aged 10 years 2 months as per MCA records.
29 Dec 2014
Cerise Pharmaceuticals Private Limited was incorporated on 29 Dec 2014.
The authorized share capital of Cerise Pharmaceuticals Private Limited is ₹ 0.20 M and paid-up capital is ₹ 0.20 M.
Currently 2 directors are associated with Cerise Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Cerise Pharmaceuticals Private Limited is Shop No.1 Chaubey Compound Sitaram Nagar Santosh Bhavan, Nallasopara (E.) India, Palgarh, Maharashtra, 401209.
The corporate identification number (CIN) of Cerise Pharmaceuticals Private Limited is U24132MH2014PTC260450 and the company number is 260450 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2017 indicates that The net worth of Cerise Pharmaceuticals Private Limited has experienced an downturn of -16.27%.
The most recent Balance Sheet for Cerise Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2018.